ATE234625T1 - Glp-1 zusammensetzungen mit verlängerter wirkdauer - Google Patents
Glp-1 zusammensetzungen mit verlängerter wirkdauerInfo
- Publication number
- ATE234625T1 ATE234625T1 AT95941606T AT95941606T ATE234625T1 AT E234625 T1 ATE234625 T1 AT E234625T1 AT 95941606 T AT95941606 T AT 95941606T AT 95941606 T AT95941606 T AT 95941606T AT E234625 T1 ATE234625 T1 AT E234625T1
- Authority
- AT
- Austria
- Prior art keywords
- glp
- extended
- during compositions
- compositions
- during
- Prior art date
Links
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 title 1
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 title 1
- 230000009974 thixotropic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Compounds Of Iron (AREA)
- Detergent Compositions (AREA)
- Soft Magnetic Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK147894 | 1994-12-23 | ||
| PCT/DK1995/000516 WO1996020005A1 (en) | 1994-12-23 | 1995-12-21 | Protracted glp-1 compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE234625T1 true ATE234625T1 (de) | 2003-04-15 |
Family
ID=8105257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95941606T ATE234625T1 (de) | 1994-12-23 | 1995-12-21 | Glp-1 zusammensetzungen mit verlängerter wirkdauer |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0796106B1 (de) |
| JP (1) | JPH10511365A (de) |
| AT (1) | ATE234625T1 (de) |
| AU (1) | AU4298596A (de) |
| DE (1) | DE69529998D1 (de) |
| WO (1) | WO1996020005A1 (de) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614492A (en) * | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
| US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
| US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
| FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
| US6284727B1 (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
| US6380357B2 (en) | 1997-12-16 | 2002-04-30 | Eli Lilly And Company | Glucagon-like peptide-1 crystals |
| SI1140148T1 (sl) * | 1998-12-22 | 2006-04-30 | Lilly Co Eli | Stabilna formulacija raztopine glukagonu podobnega peptida-1 |
| CA2358107C (en) * | 1998-12-22 | 2011-08-23 | Eli Lilly And Company | Shelf-stable formulation of glucagon-like peptide-1 |
| SI1133312T1 (sl) * | 1999-06-21 | 2008-02-29 | Lilly Co Eli | Uporaba tiazolidindionov v kombinaciji z glukagonu podobnim peptidom-1 in njegovimi agonisti za zdravljenje sladkorne bolezni, neodvisne od inzulina |
| US6926898B2 (en) | 2000-04-12 | 2005-08-09 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| WO2002043709A1 (fr) | 2000-12-01 | 2002-06-06 | Takeda Chemical Industries, Ltd. | Procede de production d'une preparation contenant une substance bioactive |
| ES2298378T3 (es) * | 2001-06-28 | 2008-05-16 | Novo Nordisk A/S | Formulacion estable de glp-1 modificado. |
| WO2005003296A2 (en) | 2003-01-22 | 2005-01-13 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| CA2841097A1 (en) | 2001-12-21 | 2003-07-24 | Human Genome Sciences, Inc. | Albumin and g-csf fusion proteins |
| AU2003208945B2 (en) | 2002-02-20 | 2008-05-01 | Emisphere Technologies, Inc | Method for administering GLP-1 molecules |
| EP1633391B1 (de) | 2003-06-03 | 2011-10-19 | Novo Nordisk A/S | Stabilisierte pharmazeutische peptid zusammensetzungen |
| KR101308912B1 (ko) | 2003-06-03 | 2013-09-23 | 노보 노르디스크 에이/에스 | 안정화된 약학적 펩티드 조성물 |
| KR101243648B1 (ko) | 2003-11-20 | 2013-03-14 | 노보 노르디스크 에이/에스 | 제조 및 주사 장치용에 최적인 프로필렌 글리콜 함유펩티드 제제 |
| US20060286129A1 (en) | 2003-12-19 | 2006-12-21 | Emisphere Technologies, Inc. | Oral GLP-1 formulations |
| JP4965446B2 (ja) | 2004-08-31 | 2012-07-04 | ノヴォ ノルディスク アー/エス | ペプチド、ポリペプチド及びタンパク質の安定化のためのトリス(ヒドロキシメチル)アミノメタンの使用 |
| RU2413530C9 (ru) | 2004-11-12 | 2021-05-18 | Ново Нордиск А/С | Стабильные препараты инсулинотропных пептидов |
| GB0511269D0 (en) | 2005-06-02 | 2005-07-13 | Creative Peptides Sweden Ab | Sustained release preparation of pro-insulin C-peptide |
| US20150157619A1 (en) | 2012-07-10 | 2015-06-11 | Takeda Pharmaceutical Company Limited | Pharmaceutical preparation for injection |
| CN105921431B (zh) | 2016-05-04 | 2018-02-06 | 京东方科技集团股份有限公司 | 一种转印板清洗设备及其清洗方法 |
| BR112020002804A2 (pt) | 2017-08-24 | 2020-07-28 | Novo Nordisk A/S | composição farmacêutica líquida, e, kit |
| TWI829687B (zh) * | 2018-05-07 | 2024-01-21 | 丹麥商諾佛 儂迪克股份有限公司 | 包含glp-1促效劑與n-(8-(2-羥基苯甲醯基)胺基)辛酸之鹽的固體組成物 |
| IL294521A (en) | 2020-02-18 | 2022-09-01 | Novo Nordisk As | glp-1 compounds and their uses |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2583257B2 (ja) * | 1986-05-05 | 1997-02-19 | ザ・ジェネラル・ホスピタル・コーポレーション | インシュリン向性ホルモン |
| JPS63218247A (ja) * | 1987-03-06 | 1988-09-12 | Yoshiaki Kawashima | 高機能懸濁液 |
| US5214035A (en) * | 1992-04-16 | 1993-05-25 | Hoechst-Roussel Agri-Vet Company | Thixotropic formulations |
| NZ250844A (en) * | 1993-04-07 | 1996-03-26 | Pfizer | Treatment of non-insulin dependant diabetes with peptides; composition |
-
1995
- 1995-12-21 DE DE69529998T patent/DE69529998D1/de not_active Expired - Lifetime
- 1995-12-21 WO PCT/DK1995/000516 patent/WO1996020005A1/en not_active Ceased
- 1995-12-21 AU AU42985/96A patent/AU4298596A/en not_active Abandoned
- 1995-12-21 JP JP8520133A patent/JPH10511365A/ja not_active Ceased
- 1995-12-21 EP EP95941606A patent/EP0796106B1/de not_active Expired - Lifetime
- 1995-12-21 AT AT95941606T patent/ATE234625T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0796106A1 (de) | 1997-09-24 |
| AU4298596A (en) | 1996-07-19 |
| WO1996020005A1 (en) | 1996-07-04 |
| DE69529998D1 (de) | 2003-04-24 |
| JPH10511365A (ja) | 1998-11-04 |
| EP0796106B1 (de) | 2003-03-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69529998D1 (de) | Glp-1 zusammensetzungen mit verlängerter wirkdauer | |
| FI920523L (fi) | Analgetiska kompositioner. | |
| DE69005438D1 (de) | Bernsteinsäureimid-Zusammensetzungen. | |
| DE3575070D1 (de) | Analgetische zusammensetzungen. | |
| DE3482781D1 (de) | Reinigungsmittelzusammensetzungen. | |
| TR26786A (tr) | Polivinilpirolidon iceren kompakt deterjan bilesimi. | |
| DE69321461D1 (de) | Desinfizierende zusammensetzung | |
| DE69423670D1 (de) | Siloxy-aluminoxan-Zusammensetzungen | |
| DE69419432D1 (de) | Bleichmittelzusammensetzungen | |
| MA22840A1 (fr) | Compositions nettoyantes. | |
| DE69300710D1 (de) | Waschmittelzusammensetzungen. | |
| DE69105462D1 (de) | Desinfizierende Zusammensetzung. | |
| DE69314540D1 (de) | Additive Zusammenstellung für Bohrlochzementierungszusammensetzungen | |
| DE69300694D1 (de) | Desinfizierende Zusammensetzungen. | |
| DE69300873D1 (de) | Waschmittelzusammensetzungen. | |
| DE3481912D1 (de) | Squarain-zusammensetzungen. | |
| DE69413612D1 (de) | Wasserstoffperoxid-Zusammensetzung | |
| DE69012475D1 (de) | Lichtempfindliche Zusammensetzungen. | |
| FI920210L (fi) | Isoleringskomposition. | |
| BR9407124A (pt) | Composições contendo surfactante | |
| MX9205264A (es) | Composiciones oleosas. | |
| DE69203507D1 (de) | Waschmittelzusammensetzung. | |
| DE3482215D1 (de) | Photopolymerisierbare zusammensetzung. | |
| FI914255L (fi) | I uv-ljus haerdbar organopolysil- oxankomposition. | |
| DE3850459D1 (de) | Lichtempfindliche Zusammensetzungen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |